Petra Stute has a problem. The hormone expert repeatedly encounters patients in her consultation who she cannot help: women who suffer from severe hot flashes but are not allowed to take hormone preparations – the usual treatment for these menopausal symptoms. That’s about to change, thanks to the new active ingredient fezolinetant. Stute, who works at the University Women’s Clinic at the Inselspital Bern in Switzerland, was able to prescribe the new drug before it was launched on the market in Germany.
Access to all STERN PLUS content and articles from the print magazine
ad-free
Already registered?
